• Martin Kaipel, Anton Prenner, Sebastian Bachl, Sebastian Farr, and Günter Sinz.
• Orthopaedic Department, Barmherzige Brüder Hospital, Johannes von Gott-Platz 1, 7000, Eisenstadt, Austria, martin.kaipel@bbeisen.at.
• Wien. Klin. Wochenschr. 2014 Apr 1; 126 (7-8): 208-11.

BackgroundAna Nova® is a novel-finned press-fit acetabular cup which showed superior biomechanical characteristics in an experimental set-up. Using Einzel Bild Röntgen Analyse (EBRA) measurements should offer the opportunity to predict implant survival at an early stage. The purpose of this study was to assess migration and clinical outcome 2 years after total hip replacement by a novel-finned press-fit acetabular cup.MethodsIn this study, migration and clinical results of the implant were prospectively assessed in 67 patients. Clinical outcome was assessed using the Harris hip score (HHS). Migration analyses were performed using the computer assisted EBRA system. Data were analyzed for normal distribution using the Kolmogorov-Smirnov test. Group comparisons were performed using the analysis of variance (ANOVA) test. P-values less than 0.05 were considered statistically significant.ResultsAt 2 years after surgery, none of the implants needed revision and HHS increased from 39.7 up to 92.2. In contrast to the beneficial clinical outcome, 17 of 44 patients showed increased total migration ( 1 mm/2a).ConclusionsAdverse migration data in this study might predict aseptic loosening and decreased survival of the implant. According to previous studies, it is possible that this effect occurred because of limited accuracy of the EBRA system. In our opinion, migration analyses may not be recommended as a screening tool in a 2 year follow-up.

36 keywords...

hide…